Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 25 of 25 publications.

Thase MF, Fava M, Hollander S, Simmons JH, Ivgy-May N, Boyle K, Gibertini M. Analysis of the effects of gepirone-ER on the Bech-6 and individual HAM-D 17-item scores. Poster presented at the 2003 42nd ACNP Annual Meeting; December 2003. San Juan, Puerto Rico.

Beard SM, Gaffney L, Bamber L. Economic modelling of antiplatelet therapy in the secondary prevention of stroke. Poster presented at the 2003 ISPOR 6th Annual European Congress; November 9, 2003. Barcelona, Spain.

von Scheele B, DePlatchett J, Gaffney L, Peña BM, Niculescu L. The total costs of treatment with valdecoxib compared to generic diclofenac are similar in patients with rheumatoid arthritis in Germany. Poster presented at the 2003 ISPOR 6th Annual European Congress; November 9, 2003. Barcelona, Spain. [abstract] Value Health. 2003 Nov; 6(6):725-6.

Pearson IV, Page MD, van Spanning RJM, Ferguson SJ. A mutant of paracoccus denitrificans with disrupted genes coding for cytochrome c550 and pseudoazurin establishes these two proteins as the in vivo electron donors to cytochrome cd1 nitrite reductase. J Bacteriol. 2003 Nov 1;185(21):6308-15.

Kroutil L, Weimer B, Candrilli SD, Smith R, Rachal V. An automated population based framework for integrating estimates of substance abuse treatment needs: implemented for the state of Missouri. Poster presented at the 18th Annual Conference of the American Evaluation Association; November 2003.

Hicks KA, Honeycutt AA, Scotton C. A model for allocating HIV prevention resources in local jurisdictions. Poster presented at the Prevention Effectiveness and Health Economics Seminar at CDC; November 2003.

Sorensen SW, Hicks KA, Wirth K, Hoerger TJ, Narayan K, Saaddine J. Optimal allocation of resources based on the diabetes report card for quality care. Presented at the Institute for Operations Research and the Management Sciences Annual Meeting; October 2003.

Neighbors DM, McCory D, Pesa J. Cost-effectiveness and budget impact of zolmitriptan nasal spray. Poster presented at the 2003 AMCP Educational Conference; October 2003. Montreal, Canada.

Abeysinghe SS, Chuzhanova N, Krawczak M, Ball EV, Cooper DN. Translocation and gross deletion breakpoints in human inherited disease and cancer I: nucleotide composition and recombination-associated motifs. Hum Mutat. 2003 Sep;22(3):229-44.

Chuzhanova N, Abeysinghe SS, Krawczak M, Cooper DN. Translocation and gross deletion breakpoints in human inherited disease and cancer II: potential involvement of repetitive sequence elements in secondary structure formation between DNA ends. Hum Mutat. 2003 Sep;22(3):245-51.

Earnshaw SR, Wirth K, Hicks KA. Pilot test of the RTI HIV prevention resource allocation tool. Presented at the Florida Department of Health; August 2003.

Hicks KA, Honeycutt AA, Earnshaw SR, Richter A. A tool for comparing allocations of HIV prevention resources. Presented at the National HIV Prevention Conference; August 2003.

Hicks KA. Using computer simulation modeling for process evaluation. Presented at the National Environmental Monitoring Conference; July 2003.

Zarkin GA, Dunlap LJ, Hicks KA, Mamo D, Mobley LR. Benefits and costs of methadone treatment: results from a lifetime simulation model. Presented at the International Health Economics Association Meeting; June 15, 2003.

Sapienza S, Sacco P, Floyd K, DiCesare J, Doan Q. Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care setting. Clin Ther. 2003 Jun;25(6):1872-87.

Hicks KA. A study of the response times of state public health labs in a chemical terrorism incident using a computer simulation model. Poster presented at the Public Health Labs Chemical Terrorism Workshop; June 2003.

Earnshaw SR, Richter A, Hicks KA, Honeycutt A. The allocation of HIV prevention funds. Poster presented at the 2003 ISPOR 8th Annual International Meeting; May 2003.

Manga N, Duffy JC, Rowe PH, Cronin MTD. A hierarchical QSAR model for urinary excretion of drugs in humans as a predictive tool for biotransformation. QSAR Comb Sci. 2003 Apr 17;22(2):263-73. doi: 10.1002/qsar.200390021

Hicks KA, Honeycutt A, Earnshaw SR, Richter A. Models for the efficient allocation of HIV prevention resources. Presented at the Community Planning Leadership Summit for HIV Prevention; March 2003.

Zarkin GA, Bray JW, Davis KL, Babor TF, Higgins-Biddle JC. The costs of screening and brief intervention for risky alcohol use. J Stud Alcohol. 2003 Jan 1;64(6):849-57.

Beard S, Gaffney L, Bamber L. Economic modelling of antiplatelet therapy in the prevention of recurrent stroke. Value Health. 2003 Jan 1;6(6):650.

Stenson P, Ball EV, Mort M, Phillips A, Shiel J, Thomas N, Abeysinghe SS. Human Gene Mutation Database (HGMD). Hum Mutat. 2003;(21):577-81.

Earnshaw SR, Richter A, Hicks K, Honeycutt A. The allocation of HIV prevention funds. Value Health. 2003 Jan 1;6(3):254.

Earnshaw SR, Dennett SL. Integer/linear mathematical programming models: a tool for allocating healthcare resources. Pharmacoeconomics. 2003 Jan 1;21(12):839-51.

Price MA, Fiore T, Tanner A, Bernier K, Puma M, Magliocca L. Evaluation of the state improvement grant (SIG) program—updated cross project analysis report. 2003.